{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:05:59Z","timestamp":1792641959477,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.breast.2025.104475","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:08:48Z","timestamp":1744150128000},"page":"104475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of routine FDG-PET\/CT on locoregional treatment decisions in breast cancer patients receiving preoperative systemic therapy"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9287-8181","authenticated-orcid":false,"given":"Jetske L.B.","family":"Gunster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Marjolein","family":"Schrijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederieke H.","family":"van Duijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel P.M.","family":"Stokkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrie A.M.","family":"Marijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid N.","family":"Scholten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.breast.2025.104475_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/cncr.21659","article-title":"Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathologic factors and the risk of death in each 5-year period","volume":"106","author":"Arriagada","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.breast.2025.104475_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-007-9556-1","article-title":"An overview of prognostic factors for long-term survivors of breast cancer","volume":"107","author":"Soerjomataram","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.breast.2025.104475_bib4","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1245\/s10434-007-9473-x","article-title":"Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer","volume":"14","author":"Yao","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"9938","key":"10.1016\/j.breast.2025.104475_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.breast.2025.104475_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaoncol.2015.4935","article-title":"Ten-year outcomes of patients with breast cancer with Cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy","volume":"2","author":"Mougalian","year":"2016","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104475_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1200\/JCO.2007.11.5352","article-title":"Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy","volume":"26","author":"Jeruss","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104475_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejca.2017.04.012","article-title":"Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: an analysis of the EORTC 10994\/BIG 1-00 study","volume":"79","author":"Gillon","year":"2017","journal-title":"Eur J Cancer"},{"issue":"32","key":"10.1016\/j.breast.2025.104475_bib9","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104475_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-023-07178-6","article-title":"Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study","volume":"204","author":"de Wild","year":"2024","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.breast.2025.104475_bib11","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s00259-024-06696-9","article-title":"Joint EANM-SNMMI guideline on the role of 2-[(18)F]FDG PET\/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI\/ESR, and EUSOMA)","volume":"51","author":"Vaz","year":"2024","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1016\/j.breast.2025.104475_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-012-2179-1","article-title":"Locoregional lymph node involvement on 18F-FDG PET\/CT in breast cancer patients scheduled for neoadjuvant chemotherapy","volume":"135","author":"Koolen","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.breast.2025.104475_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdl425","article-title":"A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases","volume":"18","author":"Veronesi","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2025.104475_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2407-8-165","article-title":"Utility of 18F-fluoro-deoxyglucose emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in combination with ultrasonography for axillary staging in primary breast cancer","volume":"8","author":"Ueda","year":"2008","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.breast.2025.104475_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-013-2678-8","article-title":"Pre-chemotherapy 18F-FDG PET\/CT upstages nodal stage in stage II-III breast cancer patients treated with neoadjuvant chemotherapy","volume":"141","author":"Koolen","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.breast.2025.104475_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0360-3016(97)00897-3","article-title":"The importance of postoperative radiation therapy in multimodality management of locally advanced breast cancer: a phase II trial of neoadjuvant MVAC, surgery, and radiation","volume":"40","author":"Abdel-Wahab","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"10.1016\/j.breast.2025.104475_bib17","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1200\/JCO.2004.11.129","article-title":"Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy","volume":"22","author":"Huang","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2025.104475_bib18","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ijrobp.2007.01.023","article-title":"Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy","volume":"68","author":"McGuire","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9503","key":"10.1016\/j.breast.2025.104475_bib19","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.breast.2025.104475_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10549-015-3642-6","article-title":"Long-term outcomes among breast cancer patients with extensive regional lymph node involvement: implications for locoregional management","volume":"154","author":"Braunstein","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.breast.2025.104475_bib21","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.7073","article-title":"Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer","volume":"97","author":"Straver","year":"2010","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.breast.2025.104475_bib22","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1245\/s10434-018-6404-y","article-title":"Major reduction in axillary lymph node dissections after neoadjuvant systemic therapy for node-positive breast cancer by combining PET\/CT and the MARI procedure","volume":"25","author":"van der Noordaa","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.breast.2025.104475_bib23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/bjs.10555","article-title":"Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy","volume":"104","author":"Koolen","year":"2017","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.breast.2025.104475_bib25","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1245\/s10434-018-6486-6","article-title":"Eighth edition of the AJCC cancer staging manual: breast cancer","volume":"25","author":"Giuliano","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104475_bib26","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.breast.2025.104475_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13550-021-00824-4","article-title":"[(18)F]FDG-PET\/CT in prone compared to supine position for optimal axillary staging and treatment in clinically node-positive breast cancer patients with neoadjuvant systemic therapy","volume":"11","author":"van Loevezijn","year":"2021","journal-title":"EJNMMI Res"},{"issue":"11","key":"10.1016\/j.breast.2025.104475_bib28","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1245\/s10434-020-08650-z","article-title":"Selecting node-positive patients for axillary downstaging with neoadjuvant chemotherapy","volume":"27","author":"Montagna","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.breast.2025.104475_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1245\/s10434-019-08154-5","article-title":"The landmark series: axillary management in breast cancer","volume":"27","author":"Fisher","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.breast.2025.104475_bib30","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2025.104475_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/SLA.0000000000001417","article-title":"Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)","volume":"262","author":"Golshan","year":"2015","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.breast.2025.104475_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-016-4006-6","article-title":"Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)","volume":"160","author":"Golshan","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.breast.2025.104475_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.breast.2025.104475_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.breast.2025.104475_bib35","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/annonc\/mdm481","article-title":"European guidelines for quality assurance in breast cancer screening and diagnosis","volume":"19","author":"Perry","year":"2008","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104475_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1148\/radiol.2493071483","article-title":"Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients","volume":"250","author":"Abe","year":"2009","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.breast.2025.104475_bib37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1148\/radiol.10100296","article-title":"Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer?","volume":"257","author":"Neal","year":"2010","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.breast.2025.104475_bib38","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.breast.2013.09.002","article-title":"Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?","volume":"22","author":"Schipper","year":"2013","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.breast.2025.104475_bib39","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.ejrad.2016.10.030","article-title":"Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients","volume":"85","author":"van Nijnatten","year":"2016","journal-title":"Eur J Radiol"},{"issue":"12","key":"10.1016\/j.breast.2025.104475_bib40","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1200\/JCO.2011.38.1103","article-title":"Prospective study of 2-[(1)(8)F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study","volume":"30","author":"Pritchard","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104475_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2015.05.012","article-title":"Impact of pretreatment combined (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography staging on radiation therapy treatment decisions in locally advanced breast cancer","volume":"93","author":"Ng","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.breast.2025.104475_bib42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00259-013-2600-y","article-title":"Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with stage III breast cancer","volume":"41","author":"Seo","year":"2014","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"18","key":"10.1016\/j.breast.2025.104475_bib43","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.ejca.2010.07.034","article-title":"Detection of extra-axillary lymph node involvement with FDG PET\/CT in patients with stage II-III breast cancer","volume":"46","author":"Aukema","year":"2010","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.breast.2025.104475_bib44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.6004\/jnccn.2020.7592","article-title":"Clinical utility of 18F-fdg PET\/CT in staging localized breast cancer before initiating preoperative systemic therapy","volume":"18","author":"Ko","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.breast.2025.104475_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.carj.2017.08.001","article-title":"Incidence and economic impact of incidental findings on (18)F-fdg PET\/CT imaging","volume":"69","author":"Adams","year":"2018","journal-title":"Can Assoc Radiol J"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:54:24Z","timestamp":1763607264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625004928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":43,"alternative-id":["S0960977625004928"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104475","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of routine FDG-PET\/CT on locoregional treatment decisions in breast cancer patients receiving preoperative systemic therapy","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104475"}}